Literature DB >> 4039013

Absence of therapeutic blood concentrations of tetracycline in rats after administration in drinking water.

W P Porter, Y S Bitar, J D Strandberg, P C Charache.   

Abstract

Because of ease of administration and broad antibacterial spectrum, tetracycline often is administered in drinking water to control infectious diseases of rats. Assay of serum after a gavage bolus of tetracycline (300 mg/kg body weight) revealed little absorption of tetracycline by this route. Rats were given water containing tetracycline at several concentrations (400 mg/liter, 4g/liter, and 4 g tetracycline plus 50 g sucrose/liter) ad libitum and serum concentrations of tetracycline were monitored. Bioassay of serum samples from these animals, taken during 72 hours of water medication, revealed no detectable tetracycline concentrations (greater than 0.2 mcg/ml) in the 400 mg and 4 g/liter groups. Two of eighteen serum samples from the group given 4 g tetracycline with 50 g sucrose/liter had minimal therapeutic tetracycline concentrations (0.3 mcg/ml) effective for Mycoplasma pulmonis. Some of the animals given tetracycline ad libitum in drinking water drank very little and lost weight compared to control animals. These findings indicate that the practice of adding tetracycline to drinking water of rats may be ineffective in controlling systemic diseases, and also be detrimental to the treated animals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039013

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  6 in total

1.  Pharmacokinetics of tetracycline in the domestic rabbit following intravenous or oral administration.

Authors:  D H Percy; W D Black
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

2.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.

Authors:  K D Moody; R L Adams; S W Barthold
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

4.  Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis.

Authors:  David Gould; Nasim Yousaf; Rewas Fatah; Maria Cristina Subang; Yuti Chernajovsky
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 5.  Respiratory diseases of rodents.

Authors:  T R Schoeb
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2000-05

6.  Tissue Distribution of Doxycycline in Animal Models of Tuberculosis.

Authors:  Martin Gengenbacher; Matthew D Zimmerman; Jansy P Sarathy; Firat Kaya; Han Wang; Marizel Mina; Claire Carter; Md Amir Hossen; Hongwei Su; Carolina Trujillo; Sabine Ehrt; Dirk Schnappinger; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.